Find → Understand → Decide
Cemiplimab
Discovery priority: MEDIUM · POSSIBLE / INVESTIGATE
Discovery priority ≠ investment recommendation. These are observation labels, not verified canonical products. Buyer qualification: UNKNOWN.
Why investigate?
Why stranded (event context): financing failure; inadequate public evidence; trial-design failure
Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established
Company/trial failed before biology? UNKNOWN
Biology implicated: UNCLEAR · Failure context: MIXED
MODEL INFERENCE · LOW confidence. Explicit asset-linked program event or documented experimental trial arm, stop scope, dated recency and biological cautions; no publication count or buyer-gate input.
Current control: UNKNOWN · Restart: UNKNOWN · Development reuse: UNKNOWN
Next diligence: Confirm present program status and exact product identity, then trace scoped rights/data/CMC and review arm-level human outcomes.
Existing buyer gates
Human Signal: UNKNOWN
Cheap Truth: UNKNOWN
Clean Rights: UNKNOWN
Market Pull: UNKNOWN
No event or publication count supplies missing gate evidence. Existing reviewed opportunities remain in their original records.
Evidence timeline
2026-08-24 · trial:NCT06385262
Registry update date, not proven program-stop date
SOURCE TEXT · Exact source
Protocol is currently undergoing study design revisions and will re-open after amendment is IRB approved
Trial reason is not attributed to every intervention; comparator/combination context needs review.
Interpretation: trial-design failure · AUTO_INFERRED · MEDIUM
Provenance and retrieval scope
{
"hash": "9760595efcbb8816175d3785b2187f35c3bddd1d45d668ca53e75635fe9548a2",
"metadata": {
"complete": false,
"content_hash": "2ca1679dad0f3f17150af6bd4f23c7bb11e653d2dd78fd7c22183dc1902caeed",
"failed": false,
"last_checked": 1790026985.182528,
"last_success": 1790026985.182528,
"live_verified": true,
"scope": "AREA[OverallStatus]SUSPENDED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)"
},
"path": "protocolSection.armsInterventionsModule.interventions",
"raw_hash": "2ca1679dad0f3f17150af6bd4f23c7bb11e653d2dd78fd7c22183dc1902caeed",
"raw_path": "research/obz7_sources/2ca1679dad0f3f17150af6bd4f23c7bb11e653d2dd78fd7c22183dc1902caeed.json",
"request_params": {
"countTotal": "true",
"format": "json",
"pageSize": 100,
"query.term": "AREA[OverallStatus]SUSPENDED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)",
"sort": "LastUpdatePostDate:desc"
},
"request_url": "https://clinicaltrials.gov/api/v2/studies",
"type": "clinicaltrials",
"url": "https://clinicaltrials.gov/study/NCT06385262"
}2026-09-01 · trial:NCT06568172
Registry update date, not proven program-stop date
SOURCE TEXT · Exact source
Other - Other
Trial reason is not attributed to every intervention; comparator/combination context needs review.
Interpretation: inadequate public evidence · AUTO_INFERRED · MEDIUM
Provenance and retrieval scope
{
"hash": "747f699a06036d670c128f99aa05687cd065d4a4250a668547091e9b426b1611",
"metadata": {
"complete": false,
"content_hash": "2ca1679dad0f3f17150af6bd4f23c7bb11e653d2dd78fd7c22183dc1902caeed",
"failed": false,
"last_checked": 1790026985.182528,
"last_success": 1790026985.182528,
"live_verified": true,
"scope": "AREA[OverallStatus]SUSPENDED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)"
},
"path": "protocolSection.armsInterventionsModule.interventions",
"raw_hash": "2ca1679dad0f3f17150af6bd4f23c7bb11e653d2dd78fd7c22183dc1902caeed",
"raw_path": "research/obz7_sources/2ca1679dad0f3f17150af6bd4f23c7bb11e653d2dd78fd7c22183dc1902caeed.json",
"request_params": {
"countTotal": "true",
"format": "json",
"pageSize": 100,
"query.term": "AREA[OverallStatus]SUSPENDED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)",
"sort": "LastUpdatePostDate:desc"
},
"request_url": "https://clinicaltrials.gov/api/v2/studies",
"type": "clinicaltrials",
"url": "https://clinicaltrials.gov/study/NCT06568172"
}2026-09-03 · trial:NCT07414992
Registry update date, not proven program-stop date
SOURCE TEXT · Exact source
The sponsor is no longer supporting the trial because they are no longer interested in studying the drug in the target patient population.
Trial reason is not attributed to every intervention; comparator/combination context needs review.
Interpretation: inadequate public evidence · AUTO_INFERRED · MEDIUM
Provenance and retrieval scope
{
"hash": "a9673e7949dd6518f87a82a38ed9f9be3d668885b253ac02622fe3460bf2b2b4",
"metadata": {
"complete": false,
"content_hash": "4cabd429cb884ebeb9efe5893ed7344dfcca71cd4076988989429865aef061a0",
"failed": false,
"last_checked": 1790026983.0118148,
"last_success": 1790026983.0118148,
"live_verified": true,
"scope": "AREA[OverallStatus]WITHDRAWN AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)"
},
"path": "protocolSection.armsInterventionsModule.interventions",
"raw_hash": "4cabd429cb884ebeb9efe5893ed7344dfcca71cd4076988989429865aef061a0",
"raw_path": "research/obz7_sources/4cabd429cb884ebeb9efe5893ed7344dfcca71cd4076988989429865aef061a0.json",
"request_params": {
"countTotal": "true",
"format": "json",
"pageSize": 100,
"query.term": "AREA[OverallStatus]WITHDRAWN AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)",
"sort": "LastUpdatePostDate:desc"
},
"request_url": "https://clinicaltrials.gov/api/v2/studies",
"type": "clinicaltrials",
"url": "https://clinicaltrials.gov/study/NCT07414992"
}2026-09-15 · trial:NCT06943664
Registry update date, not proven program-stop date
SOURCE TEXT · Exact source
Lack of funding
Trial reason is not attributed to every intervention; comparator/combination context needs review.
Interpretation: financing failure · AUTO_INFERRED · MEDIUM
Provenance and retrieval scope
{
"hash": "586b2d86a9f5c56835df090ea67f761d6895a67d84d0b507913d770d24b0926a",
"metadata": {
"complete": false,
"content_hash": "4cabd429cb884ebeb9efe5893ed7344dfcca71cd4076988989429865aef061a0",
"failed": false,
"last_checked": 1790026983.0118148,
"last_success": 1790026983.0118148,
"live_verified": true,
"scope": "AREA[OverallStatus]WITHDRAWN AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)"
},
"path": "protocolSection.armsInterventionsModule.interventions",
"raw_hash": "4cabd429cb884ebeb9efe5893ed7344dfcca71cd4076988989429865aef061a0",
"raw_path": "research/obz7_sources/4cabd429cb884ebeb9efe5893ed7344dfcca71cd4076988989429865aef061a0.json",
"request_params": {
"countTotal": "true",
"format": "json",
"pageSize": 100,
"query.term": "AREA[OverallStatus]WITHDRAWN AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)",
"sort": "LastUpdatePostDate:desc"
},
"request_url": "https://clinicaltrials.gov/api/v2/studies",
"type": "clinicaltrials",
"url": "https://clinicaltrials.gov/study/NCT06943664"
}Freshness is claim-specific
Fetching an old filing today does not establish current ownership or program status.
pipeline · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
sec · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
rights · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
contact · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
patent_assignment · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
clinicaltrials · STALE · AREA[OverallStatus]WITHDRAWN AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL) · checked 2026-09-21T21:43:03.011815+00:00
clinicaltrials · STALE · AREA[OverallStatus]WITHDRAWN AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL) · checked 2026-09-21T21:43:03.011815+00:00
clinicaltrials · STALE · AREA[OverallStatus]SUSPENDED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL) · checked 2026-09-21T21:43:05.182528+00:00
clinicaltrials · STALE · AREA[OverallStatus]SUSPENDED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL) · checked 2026-09-21T21:43:05.182528+00:00
Registry observations (4)
NCT06943664 · WITHDRAWN · PHASE2 · Lung Non-Small Cell Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Refractory Lung Non-Small Cell Carcinoma; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8 · Trial sponsor Roswell Park Cancer Institute
Reported aliases: Cemiplimab RWLC; Cemiplimab-rwlc; Libtayo; REGN 2810; REGN-2810; REGN2810. Identity, treatment role and exposure require review.
NCT07414992 · WITHDRAWN · PHASE2 · Bladder Urothelial Carcinoma · Trial sponsor Memorial Sloan Kettering Cancer Center
Reported aliases: None. Identity, treatment role and exposure require review.
NCT06568172 · SUSPENDED · PHASE3 · Eyelid Squamous Cell Carcinoma; Recurrent Eyelid Squamous Cell Carcinoma; Recurrent Skin Acantholytic Squamous Cell Carcinoma; Recurrent Skin Clear Cell Squamous Cell Carcinoma; Recurrent Skin Lymphoepithelial Carcinoma; Recurrent Skin Spindle Cell Squamous Cell Carcinoma; Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation; Resectable Eyelid Squamous Cell Carcinoma; Resectable Skin Acantholytic Squamous Cell Carcinoma; Resectable Skin Clear Cell Squamous Cell Carcinoma; Resectable Skin Lymphoepithelial Carcinoma; Resectable Skin Spindle Cell Squamous Cell Carcinoma; Resectable Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation; Skin Acantholytic Squamous Cell Carcinoma; Skin Clear Cell Squamous Cell Carcinoma; Skin Lymphoepithelial Carcinoma; Skin Spindle Cell Squamous Cell Carcinoma; Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation; Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8; Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Trial sponsor National Cancer Institute (NCI)
Reported aliases: Cemiplimab RWLC; Cemiplimab-rwlc; Libtayo; REGN 2810; REGN-2810; REGN2810. Identity, treatment role and exposure require review.
NCT06385262 · SUSPENDED · PHASE2 · Non Small Cell Lung Cancer · Trial sponsor Duke University
Reported aliases: None. Identity, treatment role and exposure require review.